IGHE and allergic disease: Analyzing survey responses from 78 851 individuals, an estimated 4.7% (95% CI, 4.4%–4.9%) of the US population reported current CMA, whereas 1.9% (95% CI, 1.8%–2.1%) met symptom-report criteria for convincing IgE-mediated allergy.